Vertex Pharmaceuticals: R&D Portfolio Management (A) Harvard Case Solution & Analysis

Vertex Pharmaceuticals, Inc, a company of drugs that have recently decided to pursue a vertically integrated business model, decided to build its clinical development and commercial capabilities and infrastructure. For the first time in its history, Vertex will select two drug candidates from their internal research portfolio of four projects to develop on its own, without the help of strategic partners. Director General and CEO Joshua Boger Vicki Sato fight that two projects to choose from. Focuses on how to select the projects and how to manage the portfolio selection. "Hide
by Gary P. Pisano, Lee Fleming, Eli Peter Strick Source: Harvard Business School 24 pages. Publication Date: June 10, 2004. Prod. #: 604101-PDF-ENG

Vertex Pharmaceuticals: R&D Portfolio Management (A) Case Solution Other Similar Case Solutions like

Vertex Pharmaceuticals: R&D Portfolio Management (A)

Share This